Correcting And Replacing Electronic Sensor Technology's ZNose(R) Provides Early Detection

Main Category: Medical Devices / Diagnostics
Article Date: 16 Feb 2009 - 4:00 PDT

email to a friend   printer friendly   opinions  

Menssana Research, Inc. at Fort Lee in New Jersey has placed an additional order with Electronic Sensor Technology (EST) (OTCBB:ESNR), a leading provider of innovative homeland security, environmental and healthcare solutions.

Dr. Michael Phillips, a medical innovator who uses breath analysis to screen for pulmonary diseases, founded Menssana Research. He has utilized the ultra-fast zNose® vapor analyzer to analyze breath samples for biomarkers for lung cancer, breast cancer, heart transplant rejection and pulmonary tuberculosis (TB). EST believes that the pioneering work of Dr. Phillips in this field of pre-screening will save many lives through early detection.

Dr. Teong Lim, CEO of EST, stated that: "EST is very excited to work with Menssana Research on this important humanitarian effort. We look forward to continuing this rewarding work."

For more information about Menssana Research and Dr. Phillips' publications, please visit the website: http://www.menssanaresearch.com.

About Electronic Sensor Technology

Founded in 1995, Electronic Sensor Technology has developed and patented a chemical vapor analysis process with applications for the homeland security, environment and healthcare markets.

SEC Filings and Forward-Looking Statements

This press release includes forward-looking statements, including the Company's expectations regarding its ability to develop and access capital markets and its ability to achieve expected results in the chemical detection and analysis industry. The forward-looking statements are identified through use of the words "potential," "anticipate," "expect," "planned" and other words of similar meaning. These forward-looking statements may be affected by the risks and uncertainties inherent in the chemical detection and analysis industry and in the Company's business. The Company cautions readers that certain important factors may have affected and could in the future affect the Company's beliefs and expectations, and could cause the actual results to differ materially from those expressed in any forward-looking statement made by or on behalf of the Company. For a discussion of these factors, please refer to our recent filings with the Securities and Exchange Commission, including our most recent report on Form 10-KSB. The Company undertakes no obligation to update forward-looking statements to reflect events or circumstances after the date hereof.

Menssana Research

• Additional
• References
• Citations